TTM
$1.06B
YoY change
+13.9%
5Y CAGR
-7.1%
Peak year (FY2021)
$2B
Cumulative net income
$18.2B
Net Income history chart for Quest Diagnostics (DGX) from 2016 to 2025
Latest: $992M
Net Income growth chart for Quest Diagnostics (DGX) from 2016 to 2025
Latest: +13.9%
Net Income history table for Quest Diagnostics (DGX) from 1996 to 2025
| FY2025 | $992M | +13.9% | +$121M | ||
| FY2024 | $871M | +2.0% | +$17M | ||
| FY2023 | $854M | -9.7% | -$92M | ||
| FY2022 | $946M | -52.6% | -$1.05B | ||
| FY2021 | $2B | +39.4% | +$564M | ||
| FY2020 | $1.43B | +66.8% | +$573M | ||
| FY2019 | $858M | +16.6% | +$122M | ||
| FY2018 | $736M | -4.7% | -$36M | ||
| FY2017 | $772M | +19.7% | +$127M | ||
| FY2016 | $645M | -9.0% | -$64M | ||
| FY2015 | $709M | +27.5% | +$153M | ||
| FY2014 | $556M | -34.5% | -$293M | ||
| FY2013 | $849M | +52.8% | +$293M | ||
| FY2012 | $556M | +18.1% | +$85.1M | ||
| FY2011 | $471M | -34.7% | -$250M | ||
| FY2010 | $721M | -1.1% | -$8.2M | ||
| FY2009 | $729M | +25.4% | +$148M | ||
| FY2008 | $582M | +71.1% | +$242M | ||
| FY2007 | $340M | -42.0% | -$246M | ||
| FY2006 | $586M | +7.3% | +$40.1M | ||
| FY2005 | $546M | +9.4% | +$47.1M | ||
| FY2004 | $499M | +14.3% | +$62.5M | ||
| FY2003 | $437M | +35.6% | +$115M | ||
| FY2002 | $322M | +98.5% | +$160M | ||
| FY2001 | $162M | +59.0% | +$60.3M | ||
| FY2000 | $102M | -3101.5% | +$105M | ||
| FY1999 | -$3.4M | -112.6% | -$30.3M | ||
| FY1998 | $26.9M | -220.6% | +$49.2M | ||
| FY1997 | -$22.3M | -96.4% | +$604M | ||
| FY1996 | -$626M | — | — |
- FY2025$992M+13.9%
- FY2024$871M+2.0%
- FY2023$854M-9.7%
- FY2022$946M-52.6%
- FY2021$2B+39.4%
- FY2020$1.43B+66.8%
- FY2019$858M+16.6%
- FY2018$736M-4.7%
- FY2017$772M+19.7%
- FY2016$645M-9.0%
- FY2015$709M+27.5%
- FY2014$556M-34.5%
- FY2013$849M+52.8%
- FY2012$556M+18.1%
- FY2011$471M-34.7%
- FY2010$721M-1.1%
- FY2009$729M+25.4%
- FY2008$582M+71.1%
- FY2007$340M-42.0%
- FY2006$586M+7.3%
- FY2005$546M+9.4%
- FY2004$499M+14.3%
- FY2003$437M+35.6%
- FY2002$322M+98.5%
- FY2001$162M+59.0%
- FY2000$102M-3101.5%
- FY1999-$3.4M-112.6%
- FY1998$26.9M-220.6%
- FY1997-$22.3M-96.4%
- FY1996-$626M—
Net Income values are taken from Quest Diagnostics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Income at Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's current net income (TTM) is $1.06B. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
The 2025 reading of Quest Diagnostics (DGX) net income is $992M – grew 13.9% year-over-year.
Over 2020–2025 (5 years), Quest Diagnostics net income expanded at a -7.1% compound annual rate, sustaining 2 straight years of year-over-year growth.
Quest Diagnostics net income plunged from $2B in 2021 to $992M in 2025, a 50.3% drawdown.
The highest annual net income of $2B was reported in 2021. The lowest in the available history was -$626M in 1996.
Quest Diagnostics Net Income by Year
Quest Diagnostics Net Income 2025: $992M
Quest Diagnostics net income in 2025 was $992M, grew 13.9% from 2024.
Quest Diagnostics Net Income 2024: $871M
2024's net income for Quest Diagnostics came in at $871M, edged up 2.0% from 2023.
Quest Diagnostics Net Income 2023: $854M
Quest Diagnostics posted net income of $854M in 2023, declined 9.7% below 2022.
Quest Diagnostics Net Income 2022: $946M
In 2022, Quest Diagnostics reported net income of $946M, plunged 52.6% below 2021.
Quest Diagnostics Net Income 2021: $2B
Quest Diagnostics net income in 2021 was $2B.
See more financial history for Quest Diagnostics (DGX).
Sector peers by Net Income
Healthcare peers of Quest Diagnostics (DGX), ranked by their latest net income
| $26.8B | |
| $20.6B | |
| $18.3B | |
| $16B | |
| $12.1B | |
| $7.71B | |
| $6.74B | |
| $4.23B |
- $26.8B
- $20.6B
- $18.3B
- $12.1B
- $7.71B
- $4.23B
Frequently asked questions
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks2.37% TTM
- Dividend Profile1.41% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History2 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.